Is nitrofurantoin safe to use during lactation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitrofurantoin Safety During Lactation

Nitrofurantoin is generally safe to use during lactation, but caution is warranted in mothers nursing infants younger than 1 month due to theoretical concerns about hemolytic anemia risk, particularly in infants with glucose-6-phosphate dehydrogenase deficiency.

Mechanism and Transfer into Breast Milk

  • Nitrofurantoin is actively transported into human milk, achieving concentrations in milk that exceed those in maternal serum 1
  • Studies show milk-to-serum concentration ratios of approximately 2.2-6.2 2, 1
  • Despite this active transport, the absolute amount transferred to the infant remains relatively small:
    • Only 0.05-0.28% of the maternal dose is excreted in breast milk 2
    • Estimated infant exposure is approximately 0.2 mg/kg/day or about 6% of the weight-adjusted maternal dose 1

Safety Considerations

General Safety

  • The 2020 American College of Rheumatology guidelines conditionally recommend nitrofurantoin as compatible with breastfeeding 3
  • Most clinical guidelines consider nitrofurantoin a first-line agent for uncomplicated UTIs, including in lactating women 4

Special Considerations for Young Infants

  • Theoretical concern exists for hemolytic anemia in newborns under 1 month of age due to:
    • Glutathione instability in very young infants
    • Potential risk in infants with glucose-6-phosphate dehydrogenase deficiency 5
  • Some experts suggest glutathione stability may be established by the eighth day of life, reducing this risk in older neonates 5

Recommendations for Clinical Practice

For Mothers Nursing Infants Older Than 1 Month

  • Nitrofurantoin can be safely used as a first-line agent for uncomplicated UTIs
  • Standard dosing regimens (100 mg twice daily for 5 days) are appropriate 4
  • No special monitoring of the infant is required

For Mothers Nursing Infants Younger Than 1 Month

  • Consider alternative antibiotics as first-line therapy if equally effective options exist
  • If alternatives are not suitable or available:
    • Nitrofurantoin can still be used with appropriate monitoring
    • The infant should be monitored by a physician for signs of hemolytic anemia (jaundice, pallor, irritability)
    • The benefits of continued breastfeeding generally outweigh the theoretical risks 5

Alternative Antibiotics During Lactation

If concerns exist about using nitrofurantoin in mothers nursing very young infants, consider:

  • Trimethoprim-sulfamethoxazole (if local resistance <20%)
  • Fosfomycin (3g single dose)
  • Beta-lactams (though they have inferior efficacy for UTIs) 4

Important Caveats

  • Nitrofurantoin is contraindicated in patients with renal impairment of any degree 6
  • Rare but serious adverse effects can occur in the mother, including pulmonary reactions and systemic inflammatory response syndrome 6, 7
  • The decision to use nitrofurantoin during lactation should balance the need for effective UTI treatment with the infant's age and risk factors

References

Research

Nitrofurantoin excretion in human milk.

Developmental pharmacology and therapeutics, 1990

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Urinary Tract Infection Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Using nitrofurantoin while breastfeeding a newborn.

Canadian family physician Medecin de famille canadien, 2014

Research

[Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections].

Medizinische Monatsschrift fur Pharmazeuten, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.